Settlement Information Website

Welcome to the McKesson Settlement Website

There is a class action lawsuit called New England Carpenters Health Benefits Fund, et al. v. First DataBank, Inc. and McKesson Corporation, Case No. 05-11148-PBS, which was approved by the federal court in Boston, Massachusetts. This lawsuit concerns how brand-name drugs are priced.

Prescription drugs often are priced using certain benchmarks. The most common pricing benchmark is called the Average Wholesale Price ("AWP"). AWP is often used in determining how much insurance companies and other Third-Party Payors will reimburse for these prescription drugs and the co-payment price that some consumers pay for them. The lawsuit claims that two Defendants, McKesson Corporation ("McKesson"), a large drug wholesaler, and First DataBank ("FDB"), a publisher of drug data, wrongfully inflated the mark-up factor used by FDB to determine the AWP for certain prescription drugs ("Subject Drugs"). The lawsuit claims that, as a result, many drug purchasers overpaid for these drugs. Both FDB and McKesson deny any wrongdoing.


Consumer Co-Pay Class

If you are a consumer and paid a percentage co-payments for any of the Subject Drugs based on AWP pricing between August 1, 2001 and March 15, 2005 and whose prescription drug plan used FDB or Medi-Span databases for determining the AWP of the Subject Drugs that are included in the McKesson Class Action.

Click Here

Consumer Cash Payor Class

If you are a consumer who was uninsured or underinsured at some period from August 1, 2001 through January 23, 2009 and purchased any of the Subject Drugs at the uninsured or "cash" price.

Click Here

Third-Party Payor Class

If you are a Third-Party Payor who reimbursed or paid for any of the Subject Drugs based on AWP pricing between August 1, 2001 and March 15, 2005 and used FDB or Medi-Span databases for determining the AWP of the Subject Drugs.

Click Here


IMPORTANT: THIS SITE IS SUPERVISED BY THE COURT AND IS ADMINISTERED BY AN ADMINISTRATION FIRM THAT HANDLES ALL ASPECTS OF NOTICE AND CLAIM PROCESSING. THIS IS THE ONLY AUTHORIZED WEB SITE FOR THIS LITIGATION. PLEASE DO NOT RELY UPON OTHER SITES THAT SET OUT DIFFERENT AND UNAUTHORIZED INFORMATION.